CA962595A - Contraceptive compositions containing a progestin and a progestagen - Google Patents

Contraceptive compositions containing a progestin and a progestagen

Info

Publication number
CA962595A
CA962595A CA123,417A CA123417A CA962595A CA 962595 A CA962595 A CA 962595A CA 123417 A CA123417 A CA 123417A CA 962595 A CA962595 A CA 962595A
Authority
CA
Canada
Prior art keywords
progestagen
progestin
compositions containing
contraceptive compositions
contraceptive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA123,417A
Other versions
CA123417S (en
Inventor
Fernando Fontanilles
Pierre A. Desaulles
Charles Kraehenbuehl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1426670A external-priority patent/CH538283A/en
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of CA962595A publication Critical patent/CA962595A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA123,417A 1970-09-25 1971-09-22 Contraceptive compositions containing a progestin and a progestagen Expired CA962595A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1426670A CH538283A (en) 1970-09-25 1970-09-25 Contraceptive product contng progestin and progestagen - for oral administration
CH1252471 1971-08-26

Publications (1)

Publication Number Publication Date
CA962595A true CA962595A (en) 1975-02-11

Family

ID=25710428

Family Applications (1)

Application Number Title Priority Date Filing Date
CA123,417A Expired CA962595A (en) 1970-09-25 1971-09-22 Contraceptive compositions containing a progestin and a progestagen

Country Status (10)

Country Link
AT (1) AT320138B (en)
AU (1) AU461935B2 (en)
BE (1) BE773064A (en)
CA (1) CA962595A (en)
DE (1) DE2146239A1 (en)
ES (1) ES395365A1 (en)
FR (1) FR2107969B1 (en)
GB (1) GB1369061A (en)
IL (1) IL37765A (en)
NL (1) NL7113201A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA939565B (en) † 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.

Also Published As

Publication number Publication date
FR2107969A1 (en) 1972-05-12
AU3380671A (en) 1973-03-29
GB1369061A (en) 1974-10-02
IL37765A (en) 1975-03-13
NL7113201A (en) 1972-03-28
AU461935B2 (en) 1975-06-12
DE2146239A1 (en) 1972-03-30
AT320138B (en) 1975-01-27
IL37765A0 (en) 1972-02-29
ES395365A1 (en) 1974-07-16
FR2107969B1 (en) 1975-04-18
BE773064A (en) 1972-03-24

Similar Documents

Publication Publication Date Title
CA947601A (en) Contraceptive device
CA920463A (en) Intra-uterine contraceptive
AU3300571A (en) Pharmaceutical compositions
AU2441971A (en) Firefighting and compositions for use therein
CA963806A (en) Contraceptive composition containing progestagen and estrogen-antagonist compounds
CA962595A (en) Contraceptive compositions containing a progestin and a progestagen
AU2682871A (en) Pharmaceutical compositions
CA995539A (en) Contraceptive devices
CA942670A (en) Contraceptive compositions
AU472706B2 (en) Anaesthetic steroid compositions
CA952902A (en) Imidazole-ribosyl cyclophosphate compounds and therapeutic compositions
AU3545971A (en) Steroid compositions
CA852987A (en) Intrauterine contraceptive device
CA843403A (en) Sustained release medicinal tablets
IL34345A (en) A contraceptive preparation containing a gestagen
IL36652A0 (en) A new oestrogenically highly active steroid of the estrane series,its manufacture and pharmaceutical compositions containing it
CA799475A (en) Sustained release medicinal composition
CA793279A (en) Sustained release medicinal composition
AU437890B2 (en) Contraceptive compositions
AU437888B2 (en) Contraceptive compositions
AU437889B2 (en) Contraceptive compositions
AU452788B2 (en) Intrauterine contraceptive device
AU473308B2 (en) Steroid anaesthetic compositions
AU457722B2 (en) Improvements relating to contraceptive devices
CA839364A (en) Copolymer composition